Evolent Health director granted 41,096 RSUs
KECK KIM reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
KECK KIM reported acquisition or exercise transactions in this Form 4 filing.
Evolent Health director Kim Keck received an equity grant that increases her direct ownership stake. She was awarded 41,096 shares of Class A Common Stock in the form of restricted stock units under the company’s 2015 Omnibus Incentive Compensation Plan, bringing her direct holdings to 102,597 shares. These units vest on the earlier of June 4, 2027, or the company’s 2027 annual meeting, as long as she continues serving on the board.
Insider Trade Summary
Grant/Award: 41,096 shares
Grant/Award
1 txn
Insider
KECK KIM
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 41,096 | $0.00 | $0.00 |
Holdings After Transaction:
Class A Common Stock — 102,597 shares (Direct)
Holdings Before and After:
Class A Common Stock, 61,501 to 102,597 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- F2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Key Figures
RSU grant size: 41,096 shares
Grant price: $0.00 per share
Total shares after grant: 102,597 shares
+1 more
4 metrics
RSU grant size
41,096 shares
Restricted stock units granted to Kim Keck on June 4, 2026
Grant price
$0.00 per share
Reported grant price for the RSUs
Total shares after grant
102,597 shares
Directly owned by Kim Keck following the transaction
Vesting date
June 4, 2027
Latest vesting date for the RSUs, or 2027 annual meeting
Key Terms
restricted stock units, Omnibus Incentive Compensation Plan, vest, beneficially owns
4 terms
restricted stock units financial
"Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
An omnibus incentive compensation plan is a single, flexible program that lets a company grant different kinds of pay — such as cash bonuses, stock options, restricted stock, or performance awards — to employees, executives and directors. Investors care because the plan affects how much ownership can be given away (dilution), how much the company spends on pay, and whether executives’ goals are aligned with shareholders, much like a menu that decides what rewards staff can pick and how costly they are.
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
beneficially owns financial
"total_shares_following_transaction: 102597.0000, indicating shares the reporting person beneficially owns after the transaction."
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Evolent Health (EVH) director Kim Keck report in this Form 4?
Kim Keck reported receiving a grant of 41,096 restricted stock units of Evolent Health Class A Common Stock. The award was made under the company’s 2015 Omnibus Incentive Compensation Plan as part of her director compensation, increasing her direct ownership position in the company.
What are the vesting terms of Kim Keck’s new Evolent Health (EVH) restricted stock units?
The 41,096 restricted stock units vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting. Vesting is conditioned on Kim Keck’s continued service with the company through the applicable vesting date specified in the grant.
Was Kim Keck’s Evolent Health (EVH) Form 4 transaction a market purchase or sale?
The Form 4 shows a grant or award acquisition, not a market purchase or sale. The 41,096 shares of Class A Common Stock were issued as restricted stock units at a reported price of $0.00 per share under the company’s incentive compensation plan.
Under which plan were Kim Keck’s new Evolent Health (EVH) restricted stock units granted?
The restricted stock units were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan governs equity-based awards, such as restricted stock units, granted to directors and other eligible participants of the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
